ISB, Partners Launch Trial to Understand, Treat COVID-19
ISB researchers are on the front lines to understand and treat COVID-19.
We have partnered with Swedish Medical Center, Stanford University, Adaptive Biotechnologies, IsoPlexis, and Metabolon — with generous initial support from the MJ Murdock Charitable Trust and the Wilke Family Foundation, which is run by Amazon co-CEO Jeff Wilke and his wife, Liesl — to launch a study of Seattle patients who have contracted COVID-19.
Our initial research will analyze 200 patients in the Seattle area, but plans are already in motion to expand our study to Providence St. Joseph Health’s hospital systems in both Portland and Southern California.
“Our objectives are two-fold,” said ISB President Dr. Jim Heath. “First, we want to understand which patients are at highest risk of severe infection, so that critical medical resources can be most effectively utilized. Second, we will develop an in-depth understanding of what constitutes an effective immune response to the virus, so as to design better vaccines or therapies.”